Biome Australia Ltd (AU:BIO) has released an update.
Biome Australia Ltd announced the issuance of 300,000 fully paid ordinary shares following the exercise of options, in compliance with the Corporations Act’s disclosure exemptions. The company, a developer of evidence-based probiotics and complementary medicines, has met all necessary provisions for the share issuance and asserts there is no undisclosed information required by investors for assessment. Biome continues to focus on improving health outcomes through its clinically supported Activated Probiotics range.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.
